CARCINOSARCOMA
Clinical trials for CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy shows promise in battle against aggressive uterine cancer
Disease control OngoingThis Phase 3 trial compares the immunotherapy drug pembrolizumab (Keytruda) to standard chemotherapy in 280 women with advanced or recurrent endometrial cancer that has a specific genetic feature (dMMR). The goal is to see if pembrolizumab can better delay cancer growth and impro…
Matched conditions: CARCINOSARCOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for endometrial cancer: targeted drug takes on chemo in major trial
Disease control OngoingThis study tests a new drug, MK-2870, against standard chemotherapy in about 710 people with endometrial cancer that has worsened after platinum chemo and immunotherapy. The goal is to see if MK-2870 helps people live longer and delays cancer growth. Participants are randomly ass…
Matched conditions: CARCINOSARCOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC